Member Exclusive Journal Content Interview

A peek behind the paper: suppressing the FGF19/FGFR4 axis in cancer

In this interview, corresponding author Yong Teng (Augusta University; GA, USA) discusses how targeting the FGF19/FGFR4 axis could be used to develop therapies for specific FGF19-driven tumors, as well as increase sensitivity to radiotherapy and chemotherapy.

Please sign in or register for FREE

No comments yet.